Advancement in Vaccine and Therapeutic

Immunization/Vaccination is one of the most cost-effective public health interventions to date, saving millions of lives and protecting countless children from illness and disability. As a direct result of immunization, polio is on the verge of eradication. Immunization has not yet realized its full potential, however. As of end-2013, 21.8 million children under 1 year of age worldwide had not received the three recommended doses of vaccine against diphtheria, tetanus and pertussis containing vaccine (DTP3), and 21.6 million children in the same age group had failed to receive a single dose of measles-containing vaccine. Given an estimated annual cohort of 133.6 million surviving infants, an additional 11.2 million children would need to have been reached during 2013 to attain 90% DTP3 coverage globally.

    Related Conference of Advancement in Vaccine and Therapeutic

    December 10-11, 2020

    2nd Pathology and Infectious Disease Conference

    Dubai, UAE
    March 18-19, 2021

    12th Tissue Repair and Regeneration Congress

    Abu Dhabi, UAE
    March 28-29, 2021

    11th Glycobiology World Congress

    Vienna, Austria
    June 11-12, 2021

    25th Global Congress on Biotechnology

    Berlin, Germany
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland

    Advancement in Vaccine and Therapeutic Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in